Alpha Tau Medical Ltd. — Company profile
Healthcare · Biotechnology · Israel
Last price 13.06 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.21B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Details
| Name | Alpha Tau Medical Ltd. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 121 |
| Founded | 2015 |
| Ceo | Uzi Sofer |
| Country | Israel |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | IL0011839383 |
| Cusip | M0740A108 |
| Cik | 1871321 |
| Sic | 3841 |
Key executives
| Name | Title |
|---|---|
| Uzi Sofer | Chief Executive Officer and Chairman |
| Raphi Levy | Chief Financial Officer |
| Amnon Gat | Chief Operations Officer |
| Ronen Segal | Chief Technology Officer |
| Dr. Robert B. Den M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
| Prof. Yona Keisari | Chief Scientific Officer |
| Rebecca Becker | Vice President of legal |
| Yael Zeiger | Corporate Controller |
Contact
| Address | Kiryat HaMada St. 5, Jerusalem, 9777605, Israel |
| Phone | 972 3 577 4115 |
| Website | https://www.alphatau.com |